NCT06516289
- Conditions
- BRCA-Mutated Breast Carcinoma, HER2-negative Breast Cancer
- Locations
-
- Breast cancer institute of Fudan University Cancer Hospital Shanghai, Shanghai Municipality, China
Clinical trial condition
BRCA-Mutated Breast Carcinoma
Explore clinical trials studying BRCA-Mutated Breast Carcinoma. Study availability and eligibility vary by location and protocol.
1 public trial
1 recruiting study